 | Up a level |
Journal Article
Poeschel, Viola, Held, Gerhard, Ziepert, Marita, Witzens-Harig, Mathias, Holte, Harald, Thurner, Lorenz, Borchmann, Peter, Viardot, Andreas, Soekler, Martin, Keller, Ulrich, Schmidt, Christian, Truemper, Lorenz, Mahlberg, Rolf, Marks, Reinhard, Hoeffkes, Heinz-Gert, Metzner, Bernd, Dierlamm, Judith, Frickhofen, Norbert, Haenel, Mathias, Neubauer, Andreas, Kneba, Michael, Merli, Francesco, Tucci, Alessandra 
ORCID: 0000-0003-3052-7463, Brown, Peter de Nully ORCID: 0000-0002-6522-4086, Federico, Massimo, Lengfelder, Eva, di Rocco, Alice, Trappe, Ralf ORCID: 0000-0001-7565-7160, Rosenwald, Andreas, Berdel, Christian, Maisenhoelder, Martin, Shpilberg, Ofer, Amam, Josif, Christofyllakis, Konstantinos ORCID: 0000-0002-0308-388X, Hartmann, Frank, Murawski, Niels, Stilgenbauer, Stephan, Nickelsen, Maike, Wulf, Gerald, Glass, Bertram, Schmitz, Norbert, Altmann, Bettina, Loeffler, Markus and Pfreundschuh, Michael
(2019).
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet, 394 (10216).
S. 2271 - 2282.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elisa, Fox, Christopher P., Schorb, Elisabeth, La Rosee, Paul, Binder, Mascha ORCID: 0000-0003-0663-3004, Fabbri, Alberto, Torri, Valter ORCID: 0000-0001-9541-9354, Minacapelli, Eleonora, Falautano, Monica, Ilariucci, Fiorella, Ambrosetti, Achille, Roth, Alexander, Hemmaway, Claire, Johnson, Peter ORCID: 0000-0003-2306-4974, Linton, Kim M., Pukrop, Tobias, Gorlov, Jette Sonderskov, Balzarotti, Monica, Hess, Georg, Keller, Ulrich, Stilgenbauer, Stephan, Panse, Jens, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Orsucci, Lorella, Pisani, Francesco, Levis, Alessandro, Krause, Stefan W., Schmoll, Hans J., Hertenstein, Bernd, Rummel, Mathias, Smith, Jeffery, Pfreundschuh, Michael, Cabras, Giuseppina, Angrilli, Francesco, Ponzoni, Maurilio, Deckert, Martina, Politi, Letterio S., Finke, Juergen, Reni, Michele, Cavalli, Franco, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald
(2017).
Whole-brain radiotherapy or autologous stem-cell transplantation as consolidation strategies after high-dose methotrexate-based chemoimmunotherapy in patients with primary CNS lymphoma: results of the second randomisation of the International Extranodal Lymphoma Study Group-32 phase 2 trial.
Lancet Haematol., 4 (11).
S. E510 - 14.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2352-3026
Ferreri, Andres J. M., Cwynarski, Kate, Pulczynski, Elko, Ponzoni, Mourilio, Deckert, Martina, Politi, Letterio S., Torri, Valter ORCID: 0000-0001-9541-9354, Fox, Christopher P., La Rosee, Paul ORCID: 0000-0002-6758-7809, Schorb, Elisabeth, Ambrosetti, Achille, Roth, Alexander, Hemmoway, Claire, Ferrari, Angela ORCID: 0000-0002-9984-1146, Linton, Kim M., Ruda, Roberta, Binder, Mascha ORCID: 0000-0003-0663-3004, Pukrop, Tobias, Balzarotti, Monica, Fabbri, Alberto, Johnson, Peter, Gorlov, Jette Sonderskov, Hess, Georg, Panse, Jens, Pisani, Francesco, Tucci, Alessandra ORCID: 0000-0003-3052-7463, Stilgenbauer, Stephan, Hertenstein, Bernd, Keller, Ulrich, Krause, Stefan W., Levis, Alessandro, Schmoll, Hans J., Covalli, Franco, Finke, Jurgen, Reni, Michele ORCID: 0000-0002-6463-0293, Zucca, Emanuele ORCID: 0000-0002-5522-6109 and Illerhaus, Gerald
(2016).
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
Lancet Haematol., 3 (5).
S. E217 - 11.
OXFORD:
ELSEVIER SCI LTD.
ISSN 2352-3026